nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—Atrioventricular block first degree—Ritonavir—acquired immunodeficiency syndrome	0.0265	0.0337	CcSEcCtD
Aclidinium—Toothache—Delavirdine—acquired immunodeficiency syndrome	0.0179	0.0227	CcSEcCtD
Aclidinium—Toothache—Saquinavir—acquired immunodeficiency syndrome	0.0159	0.0202	CcSEcCtD
Aclidinium—Dysphonia—Zidovudine—acquired immunodeficiency syndrome	0.0157	0.02	CcSEcCtD
Aclidinium—Diabetes mellitus—Amprenavir—acquired immunodeficiency syndrome	0.0157	0.02	CcSEcCtD
Aclidinium—Diabetes mellitus—Didanosine—acquired immunodeficiency syndrome	0.0143	0.0182	CcSEcCtD
Aclidinium—Diabetes mellitus—Nelfinavir—acquired immunodeficiency syndrome	0.0125	0.0159	CcSEcCtD
Aclidinium—Diabetes mellitus—Stavudine—acquired immunodeficiency syndrome	0.0124	0.0158	CcSEcCtD
Aclidinium—Dysphonia—Lamivudine—acquired immunodeficiency syndrome	0.0112	0.0143	CcSEcCtD
Aclidinium—Diabetes mellitus—Indinavir—acquired immunodeficiency syndrome	0.0101	0.0128	CcSEcCtD
Aclidinium—Nasopharyngitis—Zidovudine—acquired immunodeficiency syndrome	0.00841	0.0107	CcSEcCtD
Aclidinium—Diabetes mellitus—Ritonavir—acquired immunodeficiency syndrome	0.0084	0.0107	CcSEcCtD
Aclidinium—Cardiac failure—Delavirdine—acquired immunodeficiency syndrome	0.0081	0.0103	CcSEcCtD
Aclidinium—Diabetes mellitus—Saquinavir—acquired immunodeficiency syndrome	0.00809	0.0103	CcSEcCtD
Aclidinium—Sinusitis—Nelfinavir—acquired immunodeficiency syndrome	0.00785	0.00997	CcSEcCtD
Aclidinium—Sinusitis—Stavudine—acquired immunodeficiency syndrome	0.00782	0.00994	CcSEcCtD
Aclidinium—CHRM5—skin of body—acquired immunodeficiency syndrome	0.00762	0.0754	CbGeAlD
Aclidinium—Rhinitis—Nelfinavir—acquired immunodeficiency syndrome	0.00753	0.00956	CcSEcCtD
Aclidinium—Rhinitis—Stavudine—acquired immunodeficiency syndrome	0.0075	0.00953	CcSEcCtD
Aclidinium—Nasopharyngitis—Efavirenz—acquired immunodeficiency syndrome	0.00739	0.00939	CcSEcCtD
Aclidinium—Osteoarthritis—Ritonavir—acquired immunodeficiency syndrome	0.00731	0.00929	CcSEcCtD
Aclidinium—BCHE—blood plasma—acquired immunodeficiency syndrome	0.00723	0.0716	CbGeAlD
Aclidinium—Osteoarthritis—Saquinavir—acquired immunodeficiency syndrome	0.00704	0.00894	CcSEcCtD
Aclidinium—Eye disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00702	0.00891	CcSEcCtD
Aclidinium—Urinary retention—Ritonavir—acquired immunodeficiency syndrome	0.00695	0.00883	CcSEcCtD
Aclidinium—Sinusitis—Zidovudine—acquired immunodeficiency syndrome	0.0068	0.00864	CcSEcCtD
Aclidinium—Nervous system disorder—Amprenavir—acquired immunodeficiency syndrome	0.00659	0.00837	CcSEcCtD
Aclidinium—Rhinitis—Zidovudine—acquired immunodeficiency syndrome	0.00652	0.00829	CcSEcCtD
Aclidinium—Urinary tract disorder—Zidovudine—acquired immunodeficiency syndrome	0.00642	0.00816	CcSEcCtD
Aclidinium—Urethral disorder—Zidovudine—acquired immunodeficiency syndrome	0.00638	0.0081	CcSEcCtD
Aclidinium—Infestation NOS—Efavirenz—acquired immunodeficiency syndrome	0.00637	0.00809	CcSEcCtD
Aclidinium—Infestation—Efavirenz—acquired immunodeficiency syndrome	0.00637	0.00809	CcSEcCtD
Aclidinium—Sinusitis—Indinavir—acquired immunodeficiency syndrome	0.00632	0.00803	CcSEcCtD
Aclidinium—Dry mouth—Didanosine—acquired immunodeficiency syndrome	0.00625	0.00794	CcSEcCtD
Aclidinium—Infection—Didanosine—acquired immunodeficiency syndrome	0.00608	0.00773	CcSEcCtD
Aclidinium—CHRM4—nervous system—acquired immunodeficiency syndrome	0.00603	0.0597	CbGeAlD
Aclidinium—Nasopharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.006	0.00763	CcSEcCtD
Aclidinium—Urinary tract disorder—Indinavir—acquired immunodeficiency syndrome	0.00597	0.00759	CcSEcCtD
Aclidinium—Sinusitis—Efavirenz—acquired immunodeficiency syndrome	0.00597	0.00759	CcSEcCtD
Aclidinium—Urethral disorder—Indinavir—acquired immunodeficiency syndrome	0.00593	0.00754	CcSEcCtD
Aclidinium—Mediastinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00586	0.00745	CcSEcCtD
Aclidinium—CHRM4—central nervous system—acquired immunodeficiency syndrome	0.0058	0.0575	CbGeAlD
Aclidinium—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.0058	0.00737	CcSEcCtD
Aclidinium—Rhinitis—Efavirenz—acquired immunodeficiency syndrome	0.00573	0.00728	CcSEcCtD
Aclidinium—Sinusitis—Delavirdine—acquired immunodeficiency syndrome	0.00572	0.00726	CcSEcCtD
Aclidinium—Cough—Stavudine—acquired immunodeficiency syndrome	0.00569	0.00722	CcSEcCtD
Aclidinium—Urinary tract disorder—Efavirenz—acquired immunodeficiency syndrome	0.00564	0.00717	CcSEcCtD
Aclidinium—Urethral disorder—Efavirenz—acquired immunodeficiency syndrome	0.0056	0.00712	CcSEcCtD
Aclidinium—Cough—Abacavir—acquired immunodeficiency syndrome	0.0056	0.00712	CcSEcCtD
Aclidinium—Rhinitis—Delavirdine—acquired immunodeficiency syndrome	0.00548	0.00697	CcSEcCtD
Aclidinium—Dry mouth—Stavudine—acquired immunodeficiency syndrome	0.00542	0.00689	CcSEcCtD
Aclidinium—Infestation NOS—Saquinavir—acquired immunodeficiency syndrome	0.00542	0.00689	CcSEcCtD
Aclidinium—Infestation—Saquinavir—acquired immunodeficiency syndrome	0.00542	0.00689	CcSEcCtD
Aclidinium—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.0054	0.00686	CcSEcCtD
Aclidinium—Eye disorder—Efavirenz—acquired immunodeficiency syndrome	0.00534	0.00679	CcSEcCtD
Aclidinium—Sinusitis—Ritonavir—acquired immunodeficiency syndrome	0.00529	0.00672	CcSEcCtD
Aclidinium—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.00521	0.00663	CcSEcCtD
Aclidinium—Infection—Abacavir—acquired immunodeficiency syndrome	0.0052	0.00661	CcSEcCtD
Aclidinium—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00515	0.00655	CcSEcCtD
Aclidinium—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.00514	0.00653	CcSEcCtD
Aclidinium—Sinusitis—Saquinavir—acquired immunodeficiency syndrome	0.00509	0.00646	CcSEcCtD
Aclidinium—Rhinitis—Ritonavir—acquired immunodeficiency syndrome	0.00507	0.00644	CcSEcCtD
Aclidinium—Urinary tract disorder—Ritonavir—acquired immunodeficiency syndrome	0.00499	0.00635	CcSEcCtD
Aclidinium—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.00496	0.00631	CcSEcCtD
Aclidinium—Urethral disorder—Ritonavir—acquired immunodeficiency syndrome	0.00496	0.0063	CcSEcCtD
Aclidinium—Cough—Zidovudine—acquired immunodeficiency syndrome	0.00494	0.00628	CcSEcCtD
Aclidinium—Rhinitis—Saquinavir—acquired immunodeficiency syndrome	0.00488	0.0062	CcSEcCtD
Aclidinium—Sinusitis—Lamivudine—acquired immunodeficiency syndrome	0.00485	0.00617	CcSEcCtD
Aclidinium—Urinary tract disorder—Saquinavir—acquired immunodeficiency syndrome	0.00481	0.00611	CcSEcCtD
Aclidinium—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.00477	0.00606	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00475	0.00604	CcSEcCtD
Aclidinium—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.00473	0.00601	CcSEcCtD
Aclidinium—CHRM5—nervous system—acquired immunodeficiency syndrome	0.00471	0.0467	CbGeAlD
Aclidinium—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.00469	0.00596	CcSEcCtD
Aclidinium—Rhinitis—Lamivudine—acquired immunodeficiency syndrome	0.00466	0.00592	CcSEcCtD
Aclidinium—CHRM4—brain—acquired immunodeficiency syndrome	0.00461	0.0456	CbGeAlD
Aclidinium—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.0046	0.00585	CcSEcCtD
Aclidinium—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.0046	0.00584	CcSEcCtD
Aclidinium—Cough—Indinavir—acquired immunodeficiency syndrome	0.0046	0.00584	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.00459	0.00583	CcSEcCtD
Aclidinium—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00456	0.00579	CcSEcCtD
Aclidinium—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.00455	0.00578	CcSEcCtD
Aclidinium—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.00454	0.0449	CbGeAlD
Aclidinium—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00453	0.00576	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00452	0.00575	CcSEcCtD
Aclidinium—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00449	0.0057	CcSEcCtD
Aclidinium—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00439	0.00557	CcSEcCtD
Aclidinium—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.00438	0.00557	CcSEcCtD
Aclidinium—Cough—Efavirenz—acquired immunodeficiency syndrome	0.00434	0.00552	CcSEcCtD
Aclidinium—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00427	0.00543	CcSEcCtD
Aclidinium—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00421	0.00536	CcSEcCtD
Aclidinium—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00421	0.00535	CcSEcCtD
Aclidinium—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00419	0.00532	CcSEcCtD
Aclidinium—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00418	0.00532	CcSEcCtD
Aclidinium—Cough—Delavirdine—acquired immunodeficiency syndrome	0.00415	0.00528	CcSEcCtD
Aclidinium—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00415	0.00527	CcSEcCtD
Aclidinium—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.00414	0.00526	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00399	0.00507	CcSEcCtD
Aclidinium—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00398	0.00506	CcSEcCtD
Aclidinium—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00396	0.00504	CcSEcCtD
Aclidinium—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00396	0.00504	CcSEcCtD
Aclidinium—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00389	0.00495	CcSEcCtD
Aclidinium—Infection—Delavirdine—acquired immunodeficiency syndrome	0.00386	0.0049	CcSEcCtD
Aclidinium—Cough—Ritonavir—acquired immunodeficiency syndrome	0.00384	0.00488	CcSEcCtD
Aclidinium—Headache—Didanosine—acquired immunodeficiency syndrome	0.00384	0.00488	CcSEcCtD
Aclidinium—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00379	0.00482	CcSEcCtD
Aclidinium—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00377	0.00479	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00371	0.00472	CcSEcCtD
Aclidinium—Cough—Saquinavir—acquired immunodeficiency syndrome	0.0037	0.0047	CcSEcCtD
Aclidinium—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00367	0.00466	CcSEcCtD
Aclidinium—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00365	0.00464	CcSEcCtD
Aclidinium—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00364	0.00462	CcSEcCtD
Aclidinium—CHRM5—brain—acquired immunodeficiency syndrome	0.0036	0.0357	CbGeAlD
Aclidinium—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00358	0.00455	CcSEcCtD
Aclidinium—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00353	0.00448	CcSEcCtD
Aclidinium—Cough—Lamivudine—acquired immunodeficiency syndrome	0.00353	0.00448	CcSEcCtD
Aclidinium—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00352	0.00448	CcSEcCtD
Aclidinium—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00351	0.00446	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00351	0.00445	CcSEcCtD
Aclidinium—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.0035	0.00445	CcSEcCtD
Aclidinium—BCHE—skin of body—acquired immunodeficiency syndrome	0.00348	0.0344	CbGeAlD
Aclidinium—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00345	0.00438	CcSEcCtD
Aclidinium—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00344	0.00437	CcSEcCtD
Aclidinium—CHRM3—digestive system—acquired immunodeficiency syndrome	0.00341	0.0337	CbGeAlD
Aclidinium—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00339	0.00431	CcSEcCtD
Aclidinium—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00339	0.00431	CcSEcCtD
Aclidinium—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00338	0.0043	CcSEcCtD
Aclidinium—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00337	0.00428	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00335	0.00426	CcSEcCtD
Aclidinium—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00334	0.00425	CcSEcCtD
Aclidinium—Headache—Stavudine—acquired immunodeficiency syndrome	0.00333	0.00423	CcSEcCtD
Aclidinium—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00333	0.00423	CcSEcCtD
Aclidinium—Headache—Abacavir—acquired immunodeficiency syndrome	0.00328	0.00417	CcSEcCtD
Aclidinium—Infection—Lamivudine—acquired immunodeficiency syndrome	0.00328	0.00416	CcSEcCtD
Aclidinium—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00324	0.00411	CcSEcCtD
Aclidinium—CHRM2—nervous system—acquired immunodeficiency syndrome	0.00323	0.032	CbGeAlD
Aclidinium—CHRM1—lung—acquired immunodeficiency syndrome	0.00318	0.0315	CbGeAlD
Aclidinium—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00316	0.00402	CcSEcCtD
Aclidinium—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.00311	0.0308	CbGeAlD
Aclidinium—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.0031	0.00394	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00299	0.00379	CcSEcCtD
Aclidinium—CHRM1—nervous system—acquired immunodeficiency syndrome	0.00294	0.0292	CbGeAlD
Aclidinium—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00294	0.00374	CcSEcCtD
Aclidinium—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00294	0.00373	CcSEcCtD
Aclidinium—Headache—Zidovudine—acquired immunodeficiency syndrome	0.0029	0.00368	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00285	0.00362	CcSEcCtD
Aclidinium—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.00283	0.0281	CbGeAlD
Aclidinium—BCHE—digestive system—acquired immunodeficiency syndrome	0.00278	0.0275	CbGeAlD
Aclidinium—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00278	0.00353	CcSEcCtD
Aclidinium—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00273	0.00347	CcSEcCtD
Aclidinium—Headache—Indinavir—acquired immunodeficiency syndrome	0.00269	0.00342	CcSEcCtD
Aclidinium—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00266	0.00338	CcSEcCtD
Aclidinium—BCHE—blood—acquired immunodeficiency syndrome	0.00265	0.0262	CbGeAlD
Aclidinium—CHRM3—nervous system—acquired immunodeficiency syndrome	0.00263	0.0261	CbGeAlD
Aclidinium—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00258	0.00328	CcSEcCtD
Aclidinium—BCHE—bone marrow—acquired immunodeficiency syndrome	0.00256	0.0254	CbGeAlD
Aclidinium—BCHE—spinal cord—acquired immunodeficiency syndrome	0.00255	0.0253	CbGeAlD
Aclidinium—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00254	0.00323	CcSEcCtD
Aclidinium—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.00254	0.0251	CbGeAlD
Aclidinium—CHRM2—brain—acquired immunodeficiency syndrome	0.00247	0.0245	CbGeAlD
Aclidinium—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00247	0.00314	CcSEcCtD
Aclidinium—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00246	0.00312	CcSEcCtD
Aclidinium—BCHE—vagina—acquired immunodeficiency syndrome	0.00246	0.0243	CbGeAlD
Aclidinium—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00243	0.00309	CcSEcCtD
Aclidinium—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00237	0.00301	CcSEcCtD
Aclidinium—BCHE—lung—acquired immunodeficiency syndrome	0.00232	0.023	CbGeAlD
Aclidinium—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00228	0.0029	CcSEcCtD
Aclidinium—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00226	0.00287	CcSEcCtD
Aclidinium—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00225	0.00286	CcSEcCtD
Aclidinium—CHRM1—brain—acquired immunodeficiency syndrome	0.00225	0.0223	CbGeAlD
Aclidinium—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.0022	0.00279	CcSEcCtD
Aclidinium—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00217	0.00275	CcSEcCtD
Aclidinium—BCHE—nervous system—acquired immunodeficiency syndrome	0.00215	0.0213	CbGeAlD
Aclidinium—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.0021	0.00267	CcSEcCtD
Aclidinium—BCHE—central nervous system—acquired immunodeficiency syndrome	0.00207	0.0205	CbGeAlD
Aclidinium—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00207	0.00263	CcSEcCtD
Aclidinium—CHRM3—brain—acquired immunodeficiency syndrome	0.00201	0.0199	CbGeAlD
Aclidinium—BCHE—brain—acquired immunodeficiency syndrome	0.00164	0.0163	CbGeAlD
Aclidinium—BCHE—lymph node—acquired immunodeficiency syndrome	0.00159	0.0157	CbGeAlD
Aclidinium—CHRM1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000552	0.00492	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00055	0.00491	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000544	0.00486	CbGpPWpGaD
Aclidinium—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00054	0.00482	CbGpPWpGaD
Aclidinium—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00054	0.00482	CbGpPWpGaD
Aclidinium—CHRM4—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00054	0.00482	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000505	0.00451	CbGpPWpGaD
Aclidinium—CHRM2—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000502	0.00448	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000499	0.00445	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000497	0.00444	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000497	0.00443	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000492	0.00439	CbGpPWpGaD
Aclidinium—CHRM4—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000486	0.00434	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000484	0.00432	CbGpPWpGaD
Aclidinium—CHRM2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000472	0.00422	CbGpPWpGaD
Aclidinium—CHRM2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000472	0.00422	CbGpPWpGaD
Aclidinium—CHRM1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000472	0.00422	CbGpPWpGaD
Aclidinium—CHRM3—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000471	0.0042	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000467	0.00417	CbGpPWpGaD
Aclidinium—CHRM2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000466	0.00416	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000466	0.00416	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000461	0.00412	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000457	0.00408	CbGpPWpGaD
Aclidinium—CHRM4—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000451	0.00403	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000447	0.00399	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000446	0.00398	CbGpPWpGaD
Aclidinium—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000444	0.00396	CbGpPWpGaD
Aclidinium—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000443	0.00395	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000442	0.00394	CbGpPWpGaD
Aclidinium—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000438	0.00391	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000438	0.00391	CbGpPWpGaD
Aclidinium—CHRM5—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000432	0.00386	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00043	0.00383	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00043	0.00383	CbGpPWpGaD
Aclidinium—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000429	0.00383	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00042	0.00375	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000412	0.00367	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000412	0.00367	CbGpPWpGaD
Aclidinium—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000411	0.00367	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000409	0.00365	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000405	0.00361	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000403	0.0036	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000402	0.00359	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000399	0.00356	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000392	0.0035	CbGpPWpGaD
Aclidinium—CHRM4—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000387	0.00345	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—TAT—acquired immunodeficiency syndrome	0.000381	0.0034	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00038	0.0034	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00038	0.0034	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00038	0.00339	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000379	0.00338	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000379	0.00338	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000376	0.00335	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000376	0.00335	CbGpPWpGaD
Aclidinium—CHRM5—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00037	0.00331	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000364	0.00324	CbGpPWpGaD
Aclidinium—CHRM2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000359	0.00321	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000341	0.00304	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00034	0.00303	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000336	0.003	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000327	0.00292	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000324	0.00289	CbGpPWpGaD
Aclidinium—CHRM2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000324	0.00289	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000313	0.00279	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000308	0.00275	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000307	0.00274	CbGpPWpGaD
Aclidinium—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000304	0.00272	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000304	0.00271	CbGpPWpGaD
Aclidinium—CHRM3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000303	0.00271	CbGpPWpGaD
Aclidinium—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.0003	0.00268	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000295	0.00263	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—TAT—acquired immunodeficiency syndrome	0.000293	0.00262	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00029	0.00259	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00029	0.00259	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000289	0.00258	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000289	0.00258	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000289	0.00258	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000289	0.00257	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000286	0.00255	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000286	0.00255	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000286	0.00255	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000283	0.00253	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000282	0.00252	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000282	0.00252	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000279	0.00249	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000276	0.00246	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000275	0.00246	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000272	0.00243	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000261	0.00233	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00026	0.00232	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000259	0.00231	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000258	0.0023	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000257	0.0023	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000256	0.00228	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000255	0.00228	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000253	0.00226	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000249	0.00223	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000248	0.00222	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000248	0.00221	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000248	0.00221	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000247	0.00221	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000243	0.00217	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000243	0.00217	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000237	0.00212	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000237	0.00212	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000235	0.00209	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000233	0.00208	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000233	0.00208	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000225	0.002	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000224	0.002	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000221	0.00197	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000221	0.00197	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00022	0.00197	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00022	0.00196	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000218	0.00194	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000215	0.00192	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000211	0.00188	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000211	0.00188	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000199	0.00177	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000198	0.00177	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000196	0.00175	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000189	0.00169	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000185	0.00165	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000182	0.00162	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000177	0.00158	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000175	0.00156	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000174	0.00156	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000174	0.00156	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000174	0.00155	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000174	0.00155	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000173	0.00154	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000172	0.00153	CbGpPWpGaD
Aclidinium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00017	0.00152	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000168	0.0015	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000167	0.00149	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000167	0.00149	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000167	0.00149	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000167	0.00149	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000166	0.00149	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000165	0.00147	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000165	0.00147	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000165	0.00147	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000164	0.00146	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000164	0.00146	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000163	0.00146	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000163	0.00146	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000162	0.00144	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000162	0.00144	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000161	0.00143	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000159	0.00142	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000158	0.00141	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000158	0.00141	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000158	0.00141	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000156	0.00139	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000153	0.00137	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000153	0.00136	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000151	0.00135	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000151	0.00135	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000151	0.00135	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000149	0.00133	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000149	0.00133	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000149	0.00133	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000149	0.00133	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000148	0.00132	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000148	0.00132	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000147	0.00131	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000147	0.00131	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000147	0.00131	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000145	0.00129	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000139	0.00124	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000133	0.00118	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00013	0.00116	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00013	0.00116	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000126	0.00113	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000125	0.00111	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000125	0.00111	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000125	0.00111	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000124	0.00111	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000123	0.0011	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000123	0.00109	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000122	0.00109	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000121	0.00108	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00012	0.00107	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000119	0.00106	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000113	0.00101	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000113	0.00101	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000112	0.001	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000112	0.000998	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000112	0.000997	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000111	0.000994	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000111	0.000991	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000111	0.000989	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00011	0.000982	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000103	0.000922	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000103	0.000919	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000102	0.00091	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000102	0.000909	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000102	0.000907	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000101	0.000898	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.91e-05	0.000884	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.76e-05	0.000871	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.62e-05	0.000858	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.49e-05	0.000847	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.35e-05	0.000834	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.34e-05	0.000834	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.31e-05	0.000831	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.22e-05	0.000823	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.21e-05	0.000822	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.93e-05	0.000797	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.78e-05	0.000784	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.78e-05	0.000784	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.76e-05	0.000781	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.76e-05	0.000781	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.73e-05	0.000779	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.67e-05	0.000774	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.67e-05	0.000774	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.55e-05	0.000763	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.36e-05	0.000746	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.68e-05	0.000596	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.66e-05	0.000594	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ALB—acquired immunodeficiency syndrome	6.65e-05	0.000593	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.6e-05	0.000589	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.58e-05	0.000587	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.56e-05	0.000586	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.5e-05	0.00058	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.48e-05	0.000579	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.46e-05	0.000577	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.4e-05	0.000571	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.02e-05	0.000537	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6e-05	0.000536	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.94e-05	0.00053	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.89e-05	0.000525	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.87e-05	0.000524	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.81e-05	0.000519	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.16e-05	0.00046	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.13e-05	0.000458	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	5.11e-05	0.000456	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.94e-05	0.000441	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.92e-05	0.000439	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.48e-05	0.00031	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.47e-05	0.000309	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.46e-05	0.000309	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.45e-05	0.000308	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.43e-05	0.000306	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.42e-05	0.000305	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.03e-05	0.000271	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.9e-05	0.000259	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.04e-05	0.000182	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.04e-05	0.000182	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.02e-05	0.00018	CbGpPWpGaD
